Occudo Quantitative Strategies LP Rocket Pharmaceuticals, Inc. Transaction History

Occudo Quantitative Strategies LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$16.59 - $23.6 $212,103 - $301,726	-12,785 Reduced 54.43%	10,702 $212,000
Q1 2023 May 15, 2023	BUY	$15.79 - $22.6 $370,859 - $530,806	23,487 New	23,487 $402,000
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $203,894 - $303,452	16,483 Added 92.01%	34,397 $549,000
Q2 2022 Aug 15, 2022	SELL	$7.96 - $16.64 $27,326 - $57,125	-3,433 Reduced 16.08%	17,914 $246,000
Q1 2022 May 16, 2022	BUY	$13.16 - $23.68 $104,240 - $187,569	7,921 Added 59.0%	21,347 $339,000
Q4 2021 Feb 14, 2022	BUY	$21.52 - $36.02 $5,573 - $9,329	259 Added 1.97%	13,426 $293,000
Q3 2021 Nov 15, 2021	BUY	$27.42 - $48.97 $69,153 - $123,502	2,522 Added 23.69%	13,167 $394,000
Q2 2021 Aug 16, 2021	BUY	$39.41 - $47.25 $75,233 - $90,200	1,909 Added 21.85%	10,645 $471,000
Q1 2021 May 14, 2021	BUY	$43.34 - $65.91 $378,618 - $575,789	8,736 New	8,736 $388,000

210

93.1M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $813M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.